<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM IMMULOGIC
PHARMACEUTICAL CORPORATION REPORT ON FORM 10K FOR THE YEAR ENDED DECEMBER 31,
1999, CONSOLIDATED STATEMENT OF NET ASSETS IN LIQUIDATION AND CONSOLIDATED
STATEMENT OF CHANGES IN NET ASSETS IN LIQUIDATION AND IS QUALIFIED IN ITS
ENTIRETY BY REFERENCE TO SUCH IMMULOGIC PHARMACEUTICAL CORPORATION ON FORM 10K
FOR THE YEAR ENDED DECEMBER 31, 1999
</LEGEND>
<MULTIPLIER> 1,000
<CURRENCY> U.S. DOLLARS

                             
<PERIOD-TYPE>                   YEAR
<FISCAL-YEAR-END>                          DEC-31-1999
<PERIOD-START>                             JAN-01-1999
<PERIOD-END>                               DEC-31-1999
<EXCHANGE-RATE>                                      1
<CASH>                                           2,167
<SECURITIES>                                         0
<RECEIVABLES>                                        0
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                                 2,167
<PP&E>                                               0
<DEPRECIATION>                                       0
<TOTAL-ASSETS>                                  18,621
<CURRENT-LIABILITIES>                            1,720
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                             0
<OTHER-SE>                                           0
<TOTAL-LIABILITY-AND-EQUITY>                         0
<SALES>                                              0
<TOTAL-REVENUES>                                     0
<CGS>                                                0
<TOTAL-COSTS>                                        0
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                                      0
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                                  0
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                         0
<EPS-BASIC>                                        0
<EPS-DILUTED>                                        0<F1>
<FN>
<F1>IMMULOGIC ADOPTED THE LIQUIDATION BASIS OF ACCOUNTING EFFECTIVE JULY 1, 1999
AND THEREFORE ABOVE DATA IS NOT APPLICABLE WITH THE EXCEPTION OF ASSET AND
LIABILITY DATA.
</FN>